Table 1

Patient characteristics

n (%)Overall (n=121)Strictly lobar ICH (n=76)Other ICH (n=45)p Value
Age, mean (95% CI), years69.4 (67.2 to 69.6)71.1 (68.4 to 73.8)66.6 (62.8 to 72.4)0.05
Sex, male69 (57)41 (54)28 (62.2)0.449
History of hypertension86 (72.9)49 (67.1)37 (82.2)0.090
Smoking history39 (33.3)22 (30.1)17 (38.6)0.419
Diabetes20 (17.1)11 (15.1)9 (20.5)0.459
On statins26 (22)15 (20.6)11 (25)0.648
On antithrombotics38 (32.8)27 (37)11 (25.6)0.226
First-ever ICH68 (63)40 (62.5)28 (63.6)1.000
Lacunar infarct25 (49)11 (37.9)14 (63.6)0.093
Multiple ICHs47 (39.8)34 (46.6)13 (28.9)0.081
Microbleeds presence79 (67.5)45 (62.5)34 (75.6)0.160
Microbleeds type
 Lobar77 (64.7)45 (62.5)30 (68.2)0.556
 Deep28 (23.1)028 (63.6)<0.0001
 Mean total white matter changes score (95% CI)8.58 (7.59 to 9.57)8.21 (6.95 to 9.46)9.18 (7.53 to 10.83)0.346
 Mean total EPVS score (95% CI)4.38 (4.18 to 4.58)4.29 (4.04 to 4.54)4.53 (4.17 to 4.9)0.255
 Mean basal ganglia EPVS score (95% CI)1.50 (1.37 to 1.63)1.32 (1.18 to 1.45)1.8 (1.56 to 2.05)0.0003
 Mean centrum semiovale EPVS score (95% CI)2.85 (2.72 to 3.05)2.97 (2.76 to 3.19)2.73 (2.47 to 2.99)0.1590
EPVS centrum semiovale
 Mild: 1–107 (5.8)4 (5.3)3 (6.7)0.338*
 Moderate: 11–2036 (29.8)21 (27.6)15 (33.3)
 Frequent: 21–4043 (35.5)24 (31.6)18 (40)
 Severe: >4035 (28.9)27 (35.5)†8 (17.8)†
EPVS basal ganglia
 No EPVS2 (1.7)2 (2.6)0 (0)0.005*
 Mild: 1–1070 (57.9)51 (67.1)19 (42.2)
 Moderate: 11–2037 (30.6)20 (26.3)17 (37.8)
 Frequent: 21–4011 (9.1)3 (4)8 (17.8)
 Severe: >401 (0.8)0 (0)1 (2.2)
  • p Values refer to differences between strictly lobar (clinically probable or possible CAA) and other ICH.

  • *p Value for trend across groups.

  • †Statistically significant difference between strictly lobar (possible or probable CAA) and other ICH (see figure 2 for age-adjusted prevalences).

  • CAA, cerebral amyloid angiopathy; EPVS, enlarged perivascular spaces; ICH, intracerebral haemorrhage.